|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
230,290,000 |
Market
Cap: |
138.17(K) |
Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,580 |
52
Week Range: |
$0.0001 - $0.066 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lee David A H |
Exec. V.P and CSO |
|
2006-03-27 |
4 |
S |
$31.65 |
$14,833,912 |
D/D |
(468,686) |
185,754 |
|
- |
|
Lee David A H |
Exec. V.P and CSO |
|
2006-03-27 |
4 |
OE |
$2.42 |
$569,382 |
D/D |
235,282 |
235,282 |
|
- |
|
Ammon Carol A |
Director |
|
2006-03-27 |
4 |
S |
$31.65 |
$39,466,347 |
D/D |
(1,246,962) |
0 |
|
- |
|
Ammon Carol A |
Director |
|
2006-03-27 |
4 |
OE |
$2.42 |
$3,017,648 |
D/D |
1,246,962 |
1,246,962 |
|
- |
|
Clingen Brian T |
Director until 3/15/2006 |
|
2006-03-27 |
4 |
S |
$31.65 |
$118,688 |
D/D |
(3,750) |
16,250 |
|
- |
|
Clingen Brian T |
Director until 3/15/2006 |
|
2006-03-27 |
4 |
OE |
$11.05 |
$64,863 |
D/D |
3,750 |
5,000 |
|
- |
|
Mitchell Michael W |
Director until 3/15/2006 |
|
2006-03-27 |
4 |
S |
$31.65 |
$237,375 |
D/D |
(7,500) |
13,750 |
|
- |
|
Mitchell Michael W |
Director until 3/15/2006 |
|
2006-03-27 |
4 |
OE |
$11.00 |
$133,763 |
D/D |
7,500 |
7,500 |
|
- |
|
O Donnell Joseph T Jr |
Director |
|
2006-03-27 |
4 |
S |
$31.65 |
$474,750 |
D/D |
(15,000) |
35,000 |
|
- |
|
O Donnell Joseph T Jr |
Director |
|
2006-03-27 |
4 |
OE |
$6.88 |
$123,750 |
D/D |
15,000 |
0 |
|
- |
|
Kimmel Roger H |
Director |
|
2006-03-27 |
4 |
AS |
$31.65 |
$2,215,500 |
I/I |
(70,000) |
198,741 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-07 |
4 |
OE |
$2.42 |
$6,718 |
I/I |
2,776 |
8,284,402 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-07 |
4 |
OE |
$2.42 |
$7,277 |
I/I |
3,007 |
8,973,348 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-07 |
4 |
OE |
$2.42 |
$6,638 |
I/I |
2,743 |
8,187,738 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-07 |
4 |
OE |
$2.42 |
$7,200 |
I/I |
2,975 |
8,876,683 |
|
- |
|
Endo Pharma Llc |
Mgr of Owner Direct. of Issuer |
|
2006-03-07 |
4 |
OE |
$2.42 |
$8,608 |
D/D |
3,557 |
10,616,158 |
|
- |
|
Endo Pharma Llc |
Mgr of Owner Direct. of Issuer |
|
2006-03-01 |
4 |
OE |
$2.42 |
$4,905 |
D/D |
2,027 |
10,619,715 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-01 |
4 |
OE |
$2.42 |
$3,782 |
I/I |
1,563 |
8,190,481 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-01 |
4 |
OE |
$2.42 |
$3,828 |
I/I |
1,582 |
8,287,178 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-01 |
4 |
OE |
$2.42 |
$4,145 |
I/I |
1,713 |
8,976,354 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-03-01 |
4 |
OE |
$2.42 |
$4,102 |
I/I |
1,695 |
8,879,658 |
|
- |
|
Lankau Peter A |
President & CEO |
|
2006-03-01 |
4 |
AS |
$31.93 |
$1,393,979 |
D/D |
(43,652) |
1,332,131 |
|
- |
|
Lankau Peter A |
President & CEO |
|
2006-03-01 |
4 |
OE |
$7.25 |
$316,477 |
D/D |
43,652 |
1,375,783 |
|
- |
|
Endo Pharma Llc |
Mgr of Owner Direct. of Issuer |
|
2006-02-27 |
4 |
OE |
$2.42 |
$10,958 |
D/D |
4,528 |
10,621,742 |
|
- |
|
Connors James J Ii |
MD of Owner Director of Issuer |
|
2006-02-27 |
4 |
OE |
$2.42 |
$8,453 |
I/I |
3,493 |
8,192,044 |
|
- |
|
825 Records found
|
|
Page 16 of 33 |
|
|